Adenosine Monophosphate Deaminase 1 (AMPD1) (N-Term) Peptid
AMPD1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle AMPD1 Produkte
- AMPD1 (Adenosine Monophosphate Deaminase 1 (AMPD1))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- QKSFQRFPKT PSKYLRNIDG EAWVANESFY PVFTPPVKKG EDPFRTDNLP
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-AMPD1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AMPD1 (Adenosine Monophosphate Deaminase 1 (AMPD1))
- Hintergrund
-
Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.
Alias Symbols: AMPD1,
Protein Size: 776 - Gen-ID
- 270
- NCBI Accession
- NP_001166097
-
Sie sind hier:
